Bisphosphonate affinity to hydroxyapatite and farnesyl pyrophosphate inhibitory potency, together, drive in vivo efficacy
Main Authors: | , , , , , , , , , |
---|---|
Format: | Conference item |
Published: |
2007
|
_version_ | 1797103110034817024 |
---|---|
author | Lundy, M Ebetino, F Fei, L Xia, Z Pozzi, M Trokhan, D Phipps, R Dunford, J Triffitt, J Russell, R |
author_facet | Lundy, M Ebetino, F Fei, L Xia, Z Pozzi, M Trokhan, D Phipps, R Dunford, J Triffitt, J Russell, R |
author_sort | Lundy, M |
collection | OXFORD |
description | |
first_indexed | 2024-03-07T06:15:25Z |
format | Conference item |
id | oxford-uuid:f0eb6332-b308-41e6-8d7a-c4ca4d49a339 |
institution | University of Oxford |
last_indexed | 2024-03-07T06:15:25Z |
publishDate | 2007 |
record_format | dspace |
spelling | oxford-uuid:f0eb6332-b308-41e6-8d7a-c4ca4d49a3392022-03-27T11:51:53ZBisphosphonate affinity to hydroxyapatite and farnesyl pyrophosphate inhibitory potency, together, drive in vivo efficacyConference itemhttp://purl.org/coar/resource_type/c_5794uuid:f0eb6332-b308-41e6-8d7a-c4ca4d49a339Symplectic Elements at Oxford2007Lundy, MEbetino, FFei, LXia, ZPozzi, MTrokhan, DPhipps, RDunford, JTriffitt, JRussell, R |
spellingShingle | Lundy, M Ebetino, F Fei, L Xia, Z Pozzi, M Trokhan, D Phipps, R Dunford, J Triffitt, J Russell, R Bisphosphonate affinity to hydroxyapatite and farnesyl pyrophosphate inhibitory potency, together, drive in vivo efficacy |
title | Bisphosphonate affinity to hydroxyapatite and farnesyl pyrophosphate inhibitory potency, together, drive in vivo efficacy |
title_full | Bisphosphonate affinity to hydroxyapatite and farnesyl pyrophosphate inhibitory potency, together, drive in vivo efficacy |
title_fullStr | Bisphosphonate affinity to hydroxyapatite and farnesyl pyrophosphate inhibitory potency, together, drive in vivo efficacy |
title_full_unstemmed | Bisphosphonate affinity to hydroxyapatite and farnesyl pyrophosphate inhibitory potency, together, drive in vivo efficacy |
title_short | Bisphosphonate affinity to hydroxyapatite and farnesyl pyrophosphate inhibitory potency, together, drive in vivo efficacy |
title_sort | bisphosphonate affinity to hydroxyapatite and farnesyl pyrophosphate inhibitory potency together drive in vivo efficacy |
work_keys_str_mv | AT lundym bisphosphonateaffinitytohydroxyapatiteandfarnesylpyrophosphateinhibitorypotencytogetherdriveinvivoefficacy AT ebetinof bisphosphonateaffinitytohydroxyapatiteandfarnesylpyrophosphateinhibitorypotencytogetherdriveinvivoefficacy AT feil bisphosphonateaffinitytohydroxyapatiteandfarnesylpyrophosphateinhibitorypotencytogetherdriveinvivoefficacy AT xiaz bisphosphonateaffinitytohydroxyapatiteandfarnesylpyrophosphateinhibitorypotencytogetherdriveinvivoefficacy AT pozzim bisphosphonateaffinitytohydroxyapatiteandfarnesylpyrophosphateinhibitorypotencytogetherdriveinvivoefficacy AT trokhand bisphosphonateaffinitytohydroxyapatiteandfarnesylpyrophosphateinhibitorypotencytogetherdriveinvivoefficacy AT phippsr bisphosphonateaffinitytohydroxyapatiteandfarnesylpyrophosphateinhibitorypotencytogetherdriveinvivoefficacy AT dunfordj bisphosphonateaffinitytohydroxyapatiteandfarnesylpyrophosphateinhibitorypotencytogetherdriveinvivoefficacy AT triffittj bisphosphonateaffinitytohydroxyapatiteandfarnesylpyrophosphateinhibitorypotencytogetherdriveinvivoefficacy AT russellr bisphosphonateaffinitytohydroxyapatiteandfarnesylpyrophosphateinhibitorypotencytogetherdriveinvivoefficacy |